Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer

References

• Lindholm J , LaurbergP. Hypothyroidism and thyroid substitution: historical aspects. J. Thyroid Res.2011, 809341 (2011).
   PubMedGoogle Scholar
• Mateo RCI , HennesseyJV. Thyroxine and treatment of hypothyroidism: seven decades of experience. Endocrine66(1), 10–17 (2019).
   PubMed Web of Science ®Google Scholar
• Salvatore D , DaviesTF , SohlumbergerMJ , HayID , ReedLarsen P. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Williams Textbook of Endocrinology (12th edition).MelmedS, KoenigR, RosenC, AuchusR, AllisonGoldfine A ( Eds.). Elsevier Saunders, Philadelphia, PA, USA (2011).
   Google Scholar
• Gauthier BR , Sola-GarcíaA , Cáliz-MolinaMÁet al. Thyroid hormones in diabetes, cancer, and aging. Aging Cell19(11), e13260 (2020).
   PubMed Web of Science ®Google Scholar
• Krashin E , Piekiełko-WitkowskaA , EllisMet al. Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Front. Endocrinol. (Lausanne)10, 59 (2019).
   PubMed Web of Science ®Google Scholar
• Davis PJ , LeonardJL , LinHY , LeinungM , MousaSA. Molecular basis of nongenomic actions of thyroid hormone. Vitam. Horm.106, 67–96 (2018).
   PubMed Web of Science ®Google Scholar
• Liu YC , YehCT , LinKH. Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int. J. Mol. Sci.20(20), 4986 (2019).
   PubMed Web of Science ®Google Scholar
• Davis PJ , GogliaF , LeonardJL. Nongenomic actions of thyroid hormone. Nat. Rev. Endocrinol.12(2), 111–121 (2016).
   PubMed Web of Science ®Google Scholar
• Hercbergs A . Clinical implications and impact of discovery of the thyroid hormone receptor on integrin αvβ3 – a review. Front. Endocrinol. (Lausanne)10, 565 (2019).
   PubMed Web of Science ®Google Scholar
• Davis PJ , MousaSA , LinHY. Nongenomic actions of thyroid hormone: the integrin component. Physiol. Rev.101(1), 319–352 (2021).
   PubMed Web of Science ®Google Scholar
• Flamant F , ChengSY , HollenbergANet al. Thyroid hormone signaling pathways: time for a more precise nomenclature. Endocrinology158(7), 2052–2057 (2017).
   PubMed Web of Science ®Google Scholar
• Goemann IM , RomittiM , MeyerELSet al. Role of thyroid hormones in the neoplastic process: an overview. Endocr. Relat. Cancer24(11), R367–R385 (2017).
   PubMed Web of Science ®Google Scholar
• Hennessey JV . Historical and current perspective in the use of thyroid extracts for the treatment of hypothyroidism. Endocr. Pract.21(10), 1161–1170 (2015).
   PubMed Web of Science ®Google Scholar
• Beatson GT . On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Trans. Med. Chir. Soc. Edinb.15, 153–179 (1896).
   PubMedGoogle Scholar
• Morris HP , DubnikCS , DaltonAJ. Effect of prolonged ingestion of thiourea on mammary glands and the appearance of mammary tumors in adult C3H mice. J. Natl Cancer Inst.7(3), 159–169 (1946).
   PubMedGoogle Scholar
• Dubnik CS , MorrisHP , DaltonAJ. Inhibition of mammary-gland development and mammary-tumor formation in female C3H mice following ingestion of thiouracil. J. Natl Cancer Inst.10(4), 815–841 (1950).
   PubMedGoogle Scholar
• Cheng SY , LeonardJL , DavisPJ. Molecular aspects of thyroid hormone actions. Endocr. Rev.31(2), 139–170 (2010).
   PubMed Web of Science ®Google Scholar
• Pappas L , XuXL , AbramsonDHet al. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies. Adv. Biol. Regul.64, 20–32 (2017).
   PubMedGoogle Scholar
• Suhane S , RamanujanVK. Thyroid hormone differentially modulates Warburg phenotype in breast cancer cells. Biochem. Biophys. Res. Commun.414(1), 73–78 (2011).
   PubMed Web of Science ®Google Scholar
• Liao CH , YehSC , HuangYHet al. Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion. Endocr. Relat. Cancer17(1), 99–111 (2010).
   PubMed Web of Science ®Google Scholar
• Kowalik MA , PuligaE , CabrasLet al. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming. J. Hepatol.72(6), 1159–1169 (2020).
   PubMed Web of Science ®Google Scholar
• De Luca R , DavisPJ , LinHYet al. Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome. Front. Cell Dev. Biol.8, 614030 (2021).
   PubMed Web of Science ®Google Scholar
• Montesinos MDM , PellizasCG. Thyroid hormone action on innate immunity. Front. Endocrinol. (Lausanne)10, 350 (2019).
   PubMed Web of Science ®Google Scholar
• Perrotta C , BuldoriniM , AssiEet al. The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation. Am. J. Pathol.184(1), 230–247 (2014).
   PubMed Web of Science ®Google Scholar
• Hoare M , NaritaM. The power behind the throne: senescence and the hallmarks of cancer. Annu. Rev. Cancer Biol.2, 175–194 (2018).
   Google Scholar
• Wenzek C , BoelenA , WestendorfAM , EngelDR , MoellerLC , FührerD. The interplay of thyroid hormones and the immune system – where we stand and why we need to know about it. Eur. J. Endocrinol.186(5), R65–R77 (2022).
   PubMed Web of Science ®Google Scholar
• Schmohl KA , MüllerAM , WechselbergerAet al. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3. Endocr. Relat. Cancer22(6), 941–952 (2015).
   PubMed Web of Science ®Google Scholar
• Garmendia Madariaga A , SantosPalacios S , Guillén-GrimaF , GalofréJC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab.99(3), 923–931 (2014).
   PubMed Web of Science ®Google Scholar
• Sung H , FerlayJ , SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Hamnvik OP , LarsenPR , MarquseeE. Thyroid dysfunction from antineoplastic agents. J. Natl Cancer Inst.103(21), 1572–1587 (2011).
   PubMedGoogle Scholar
• Carter Y , SippelRS , ChenH. Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management. Oncologist19(1), 34–43 (2014).
   PubMed Web of Science ®Google Scholar
• Bhattacharya S , GoyalA , KaurPet al. Anticancer drug-induced thyroid dysfunction. Eur. Endocrinol.16(1), 32–39 (2020).
   PubMedGoogle Scholar
• Torino F , BarnabeiA , BaldelliR , AppetecchiaM. Thyroid function abnormalities in patients receiving anticancer agents. In: Thyroid Hormone.AgrawalN. ( Ed.). IntechOpen (2012).
   Google Scholar
• Torino F , BarnabeiA , ParagliolaRet al. Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid23(11), 1345–1366 (2013).
   PubMed Web of Science ®Google Scholar
• Deligiorgi MV , PanayiotidisMI , TrafalisDT. Endocrine adverse events related with immune checkpoint inhibitors: an update for clinicians. Immunotherapy12(7), 481–510 (2020).
   PubMed Web of Science ®Google Scholar
• Chalan P , DiDalmazi G , PaniFet al. Thyroid dysfunctions secondary to cancer immunotherapy. J. Endocrinol. Invest.41(6), 625–638 (2018).
   PubMed Web of Science ®Google Scholar
• Hattersley R , NanaM , LansdownAJ. Endocrine complications of immunotherapies: a review. Clin. Med. (Lond.)21(2), e212–e222 (2021).
   PubMed Web of Science ®Google Scholar
• Gabora K , PiciuA , BădulescuICet al. Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors. Drug Metab. Rev.51(4), 562–569 (2019).
   PubMed Web of Science ®Google Scholar
• Reiners C , DrozdV , YamashitaS. Hypothyroidism after radiation exposure: brief narrative review. J. Neural. Transm. (Vienna)127(11), 1455–1466 (2020).
   PubMed Web of Science ®Google Scholar
• Zhou L , ChenJ , TaoCJ , ChenM , YuZH , ChenYY. Research progress of radiation-induced hypothyroidism in head and neck cancer. J. Cancer12(2), 451–459 (2021).
   PubMed Web of Science ®Google Scholar
• Makita N , ManakaK , SatoJ , MitaniK , NangakuM , IiriT. Bexarotene-induced hypothyroidism: characteristics and therapeutic strategies. Clin. Endocrinol. (Oxf.)91(1), 195–200 (2019).
   PubMed Web of Science ®Google Scholar
• Dragnev KH , WhymanJD , HahnCKet al. A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small-cell lung cancer. J. Thorac. Dis.10(9), 5531–5537 (2018).
   PubMed Web of Science ®Google Scholar
• Bednarczuk T , BrixTH , SchimaW , ZettinigG , KahalyGJ. 2021 European Thyroid Association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction. Eur. Thyroid J.10(4), 269–284 (2021).
   PubMed Web of Science ®Google Scholar
• Persani L , BrabantG , DattaniMet al. 2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism. Eur. Thyroid J.7(5), 225–237 (2018).
   PubMed Web of Science ®Google Scholar
• Garber JR , CobinRH , GharibHet al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract.18(6), 988–1028 (2012).
   PubMed Web of Science ®Google Scholar
• Vasileiou M , GilbertJ , FishburnS , BoelaertK. Guideline Committee. Thyroid disease assessment and management: summary of NICE guidance. BMJ368, m41 (2020).
   PubMedGoogle Scholar
• Deligiorgi MV , TrafalisDT. The clinical relevance of hypothyroidism in patients with solid non-thyroid cancer: a tantalizing conundrum. J. Clin. Med.11(12), 3417 (2022).
   PubMed Web of Science ®Google Scholar
• Hercbergs A , LeithJT. Spontaneous remission of metastatic lung cancer following myxedema coma – an apoptosis-related phenomenon?J. Natl Cancer Inst.85(16), 1342–1343 (1993).
   PubMedGoogle Scholar
• Hercbergs A . The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia – a novel paradigm. In Vivo10(2), 245–247 (1996).
   PubMed Web of Science ®Google Scholar
• Keestra S , HögqvistTabor V , AlvergneA. Reinterpreting patterns of variation in human thyroid function: an evolutionary ecology perspective. Evol. Med. Public Health9(1), 93–112 (2020).
   PubMed Web of Science ®Google Scholar
• Burch HB . Drug effects on the thyroid. N. Engl. J. Med.381(8), 749–761 (2019).
   PubMed Web of Science ®Google Scholar
• Abualia M , AmarinJZ , ZayedAA. Drug effects on the thyroid. N. Engl. J. Med.381(20), 1979–1980 (2019).
   PubMedGoogle Scholar
• Benvenga S . L-T4 therapy in the presence of pharmacological interferents. Front. Endocrinol. (Lausanne)11, 607446 (2020).
   PubMed Web of Science ®Google Scholar
• Wiersinga WM , DuntasL , FadeyevV , NygaardB , VanderpumpMP. 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J.1(2), 55–71 (2012).
   PubMedGoogle Scholar
• Jonklaas J , BiancoAC , CappolaARet al. Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Thyroid31(2), 156–182 (2021).
   PubMed Web of Science ®Google Scholar
• Bekkering GE , AgoritsasT , LytvynLet al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ365, l2006 (2019).
   PubMed Web of Science ®Google Scholar
• Hoermann R , MidgleyJEM , LarischR , DietrichJW. Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options. Drugs Context8, 212597 (2019).
   PubMedGoogle Scholar
• Shinkov A , BorissovaAM , KovatchevaR , AtanassovaI , VlahovJ , DakovskaL. The prevalence of the metabolic syndrome increases through the quartiles of thyroid stimulating hormone in a population-based sample of euthyroid subjects. Arq. Bras. Endocrinol. Metabol.58(9), 926–932 (2014).
   PubMedGoogle Scholar
• Cornelli U , BelcaroG , RecchiaM , FincoA. Levothyroxine and lung cancer in females: the importance of oxidative stress. Reprod. Biol. Endocrinol.11, 75 (2013).
   PubMed Web of Science ®Google Scholar
• Sarosiek K , GandhiAV , SaxenaSet al. Hypothyroidism in pancreatic cancer: role of exogenous thyroid hormone in tumor invasion-preliminary observations. J. Thyroid Res.2016, 2454989 (2016).
   PubMedGoogle Scholar
• Wu CC , IslamMM , NguyenPAet al. Risk of cancer in long-term levothyroxine users: r etrospective population-based study. Cancer Sci.112(6), 2533–2541 (2021).
   PubMed Web of Science ®Google Scholar
• Boursi B , HaynesK , MamtaniR , YangYX. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk. J. Natl Cancer Inst.107(6), djv084 (2015).
   PubMedGoogle Scholar
• Rennert G , RennertHS , PinchevM , GruberSB. A case–control study of levothyroxine and the risk of colorectal cancer. J. Natl Cancer Inst.102(8), 568–572 (2010).
   PubMedGoogle Scholar
• Friedman GD , SchwalbeJS , HabelLA. Re: a case–control study of levothyroxine and the risk of colorectal cancer. J. Natl Cancer Inst.103(21), 1637–1639 (2011).
   PubMedGoogle Scholar
• Tosovic A , BondesonAG , BondesonL , EricssonUB , MalmJ , ManjerJ. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Breast Cancer Res.12(3), R33 (2010).
   PubMed Web of Science ®Google Scholar
• Tosovic A , BondesonAG , BondesonL , EricssonUB , ManjerJ. Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study. Eur. J. Endocrinol.168(4), 483–490 (2013).
   PubMed Web of Science ®Google Scholar
• Tosovic A , BondesonAG , BondesonL , EricssonUB , ManjerJ. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC Cancer14, 536 (2014).
   PubMed Web of Science ®Google Scholar
• Leese GP , Soto-PedreE , DonnellyLA. Liothyronine use in a 17-year observational population-based study – the TEARS study. Clin. Endocrinol.85(6), 918–925 (2016).
   PubMed Web of Science ®Google Scholar
• Nogueira CR , BrentaniMM. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J. Steroid Biochem. Mol. Biol.59(3-4), 271–279 (1996).
   PubMed Web of Science ®Google Scholar
• Hall LC , SalazarEP , KaneSR , LiuN. Effects of thyroid hormones on human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol.109(1-2), 57–66 (2008).
   PubMed Web of Science ®Google Scholar
• Planck T , HedbergF , CalissendorffJ , NilssonA. Liothyronine use in hypothyroidism and its effects on cancer and mortality. Thyroid31(5), 732–739 (2021).
   PubMed Web of Science ®Google Scholar
• Deligiorgi MV , SagredouS , VakkasL , TrafalisDT. The continuum of thyroid disorders related to immune checkpoint inhibitors: still many pending queries. Cancers (Basel)13(21), 5277 (2021).
   PubMed Web of Science ®Google Scholar
• Brahmer JR , LacchettiC , SchneiderBJet al. National Comprehensive Cancer Network. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol.36(17), 1714–1768 (2018).
   PubMed Web of Science ®Google Scholar
• Shao W , KuhnC , MayrDet al. Cytoplasmic and nuclear forms of thyroid hormone receptor β1 are inversely associated with survival in primary breast cancer. Int. J. Mol. Sci.21(1), 330 (2020).
   PubMed Web of Science ®Google Scholar
• Frau C , LoiR , PetrelliAet al. Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats. Hepatology61(1), 249–259 (2015).
   PubMed Web of Science ®Google Scholar
• Park JW , ZhaoL , WillinghamM , ChengSY. Oncogenic mutations of thyroid hormone receptor β. Oncotarget6(10), 8115–8131 (2015).
   PubMedGoogle Scholar
• Ling Y , LingX , FanL , WangY , LiQ. Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population. OncoTargets Ther.8, 2967–2972 (2015).
   PubMed Web of Science ®Google Scholar
• Chung IH , ChenCY , LinYHet al. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. Oncotarget6(17), 15050–15064 (2015).
   PubMedGoogle Scholar
• Zehni AZ , BatzF , VattaiAet al. The prognostic impact of retinoid X receptor and thyroid hormone receptor alpha in unifocal vs. multifocal/multicentric breast cancer. Int. J. Mol. Sci.22(2), 957 (2021).
   PubMed Web of Science ®Google Scholar
• Moriggi G , Verga FalzacappaC , MangialardoCet al. Thyroid hormones (T3 and T4): dual effect on human cancer cell proliferation. Anticancer Res.31(1), 89–96 (2011).
   PubMed Web of Science ®Google Scholar
• Brandt J , BorgquistS , AlmgrenPet al. Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer study. Int. J. Cancer142(7), 1309–1321 (2018).
   PubMed Web of Science ®Google Scholar
• Hercbergs A , JohnsonRE , Ashur-FabianO , GarfieldDH , DavisPJ. Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study. Oncologist20(1), 72–76 (2015).
   PubMed Web of Science ®Google Scholar
• Zhou X , DuJ , WangHet al. Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR. Cell Commun. Signal.18(1), 142 (2020).
   PubMed Web of Science ®Google Scholar
• Calmeiro J , CarrascalMA , TavaresARet al. Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells. Pharmaceutics12(2), 158 (2020).
   PubMed Web of Science ®Google Scholar
• Davis PJ , DavisFB , MousaSA , LuidensMK , LinHY. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu. Rev. Pharmacol. Toxicol.51, 99–115 (2011).
   PubMed Web of Science ®Google Scholar
• Davis PJ , MousaSA , LinHY. Nongenomic actions of thyroid hormone: the integrin component. Physiol. Rev.101(1), 319–352 (2021).
   PubMed Web of Science ®Google Scholar
• Huang TY , ChangTC , ChinYTet al. NDAT targets PI3K-mediated PD-L1 upregulation to reduce proliferation in gefitinib-resistant colorectal cancer. Cells9(8), 1830 (2020).
   PubMed Web of Science ®Google Scholar
• Davis PJ , GogliaF , LeonardJL. Nongenomic actions of thyroid hormone. Nat. Rev. Endocrinol.12(2), 111–121 (2016).
   PubMed Web of Science ®Google Scholar
• Ashur-Fabian O , ZlotoO , FabianIet al. Tetrac delayed the onset of ocular melanoma in an orthotopic mouse model. Front. Endocrinol. (Lausanne)9, 775 (2019).
   PubMed Web of Science ®Google Scholar
• Yang YSH , KoPJ , PanYSet al. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers. J. Biomed. Sci.28(1), 24 (2021).
   PubMed Web of Science ®Google Scholar
• Leith JT , MousaSA , HercbergsA , LinHY , DavisPJ. Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone. Oncotarget9(97), 37069–37075 (2018).
   PubMedGoogle Scholar
• Columbano A , ChielliniG , KowalikMA. GC-1: a thyromimetic with multiple therapeutic applications in liver disease. Gene Expr.17(4), 265–275 (2017).
   PubMedGoogle Scholar
• Leow MKS , GoedeSL. The homeostatic set point of the hypothalamus–pituitary–thyroid axis – maximum curvature theory for personalized euthyroid targets.Ther. Biol. Med. Model.11, 35 (2014).
   PubMed Web of Science ®Google Scholar
• Goede SL , LeowMK , SmitJW , DietrichJW. A novel minimal mathematical model of the hypothalamus–pituitary–thyroid axis validated for individualized clinical applications. Math. Biosci.249, 1–7 (2014).
   PubMed Web of Science ®Google Scholar
• Huang PS , ChangCC , WangCS , LinKH. Functional roles of non-coding RNAs regulated by thyroid hormones in liver cancer. Biomed. J.44(3), 272–284 (2021).
   PubMed Web of Science ®Google Scholar
• Huang PS , WangCS , YehCT , LinKH. Roles of thyroid hormone-associated microRNAs affecting oxidative stress in human hepatocellular carcinoma. Int. J. Mol. Sci.20(20), 5220 (2019).
   PubMed Web of Science ®Google Scholar
• Lin YH , WuMH , LiaoCJet al. Repression of microRNA-130b by thyroid hormone enhances cell motility. J. Hepatol.62(6), 1328–1340 (2015).
   PubMed Web of Science ®Google Scholar
• Lin YH , LiaoCJ , HuangYHet al. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells. Oncogene32(38), 4509–4518 (2013).
   PubMed Web of Science ®Google Scholar
• Hijazo-Pechero S , AlayA , MarínRet al. Gene expression profiling as a potential tool for precision oncology in non-small-cell lung cancer. Cancers13(19), 4734 (2021).
   PubMed Web of Science ®Google Scholar
• Perkel JM . Single-cell analysis enters the multiomics age. Nature595, 614–616 (2021).
   Web of Science ®Google Scholar
• Schiera G , DiLiegro CM , DiLiegro I. Involvement of thyroid hormones in brain development and cancer. Cancers13(11), 2693 (2021).
   PubMed Web of Science ®Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT03823859 (Accessed September142021).
   Google Scholar
• L’Heureux A , WielandDR , WengCHet al. Association between thyroid disorders and colorectal cancer risk in adult patients in Taiwan. JAMA Netw. Open2(5), e193755 (2019).
   PubMed Web of Science ®Google Scholar
• Shinkov A , BorissovaAM , KovatchevaR , AtanassovaI , VlahovJ , DakovskaL. The prevalence of the metabolic syndrome increases through the quartiles of thyroid stimulating hormone in a population-based sample of euthyroid subjects. Arq. Bras. Endocrinol. Metabol.58(9), 926–932 (2014).
   PubMedGoogle Scholar
• Esposito K , ChiodiniP , ColaoA , LenziA , GiuglianoD. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care35(11), 2402–2411 (2012).
   PubMed Web of Science ®Google Scholar
• Dobrinja C , ScomersiS , GiudiciFet al. Association between benign thyroid disease and breast cancer: a single center experience. BMC Endocr. Disord.19(1), 104 (2019).
   PubMed Web of Science ®Google Scholar
• Rappaport J . Changes in dietary iodine explains increasing incidence of breast cancer with distant involvement in young women. J. Cancer8(2), 174–177 (2017).
   PubMed Web of Science ®Google Scholar
• Davis PJ , GlinskyGV , LinHYet al. Cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac. Front. Endocrinol. (Lausanne)5, 240 (2015).
   PubMed Web of Science ®Google Scholar
• Chu YD , YehCT. The molecular function and clinical role of thyroid stimulating hormone receptor in cancer cells. Cells9(7), 1730 (2020).
   PubMed Web of Science ®Google Scholar
• Rowe CW , PaulJW , GedyeCet al. Targeting the TSH receptor in thyroid cancer. Endocr. Relat. Cancer24(6), R191–R202 (2017).
   PubMed Web of Science ®Google Scholar
• Davis PJ , TangHY , HercbergsA , LinHY , KeatingKA , MousaSA. Bioactivity of thyroid hormone analogs at cancer cells. Front. Endocrinol. (Lausanne)9, 739 (2018).
   PubMed Web of Science ®Google Scholar
• Louzada RA , CarvalhoDP. Similarities and differences in the peripheral actions of thyroid hormones and their metabolites. Front. Endocrinol.9, 394 (2018).
   PubMed Web of Science ®Google Scholar
• Köhrle J . The colorful diversity of thyroid hormone metabolites. Eur. Thyroid J.8(3), 115–129 (2019).
   PubMed Web of Science ®Google Scholar
• Saponaro F , SestitoS , RunfolaMet al. Selective thyroid hormone receptor-beta (TRβ) agonists: new perspectives for the treatment of metabolic and neurodegenerative disorders. Front. Med.7, 331 (2020).
   Web of Science ®Google Scholar
• Wahdan-Alaswad RS , EdgertonSM , SalemHet al. Exogenous thyroid hormone is associated with shortened survival and upregulation of high-risk gene expression profiles in steroid receptor-positive breast cancers. Clin. Cancer Res.27(2), 585–597 (2021).
   PubMed Web of Science ®Google Scholar
• Hsieh MT , WangLM , ChangouCAet al. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells. Oncotarget8(15), 24237–24249 (2017).
   PubMedGoogle Scholar
• Thuillier P , JolyC , AlaviZet al. Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free survival and overall survival in non-small-cell lung cancer: an original cohort study. Cancer Immunol. Immunother.70(7), 2023–2033 (2021).
   PubMed Web of Science ®Google Scholar
• Funazo TY , NomizoT , OzasaHet al. Clinical impact of low serum free T4 in patients with non-small-cell lung cancer treated with nivolumab. Sci. Rep.9(1), 17085 (2019).
   PubMedGoogle Scholar
• Nearchou A , ValachisA , LindPet al. Acquired hypothyroidism as a predictive marker of outcome in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a literature-based meta-analysis. Clin. Genitourin. Cancer13(4), 280–286 (2015).
   PubMed Web of Science ®Google Scholar
• Vasileiadis T , ChrisofosM , SafioleasMet al. Impact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer. BMC Cancer19(1), 407 (2019).
   PubMedGoogle Scholar
• Jardim DL , DeMelo Gagliato D , NikanjamMet al. Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds. Oncoimmunology9(1), 1710052 (2020).
   PubMed Web of Science ®Google Scholar
• Deligiorgi MV , SiasosG , VakkasL , TrafalisDT. Charting the unknown association of COVID-19 with thyroid cancer, focusing on differentiated thyroid cancer: a call for caution. Cancers (Basel)13(22), 5785 (2021).
   PubMed Web of Science ®Google Scholar